Compounded vs. Branded Medications: What You Need to Know

If you've explored telehealth treatment options, you've likely seen the term "compounded medication." It's a concept that causes confusion, so here's a straightforward explanation of what it means and how it compares to FDA-approved branded drugs.

What Is Compounding?

Compounding is the practice of creating customized medications by combining, mixing, or altering ingredients to meet a specific patient's needs. It's performed by licensed compounding pharmacies under strict quality controls.

Compounding has existed for centuries. Before the rise of mass-produced pharmaceuticals, all medications were compounded. Today, it fills gaps where commercially available medications don't meet patient needs.

How Compounded Medications Differ from Branded Drugs

Branded medications (like Wegovy or Ozempic) are manufactured by pharmaceutical companies, undergo FDA approval for specific indications, and are sold at prices set by the manufacturer.

Compounded medications may use the same generic drug substance as an FDA-approved product, but they are prepared by a licensed pharmacy rather than the brand manufacturer. They are not FDA-approved and should not be presented as equivalent to a branded product simply because they involve the same underlying drug substance.

Key differences:

• Price: Compounded pricing can differ from brand pricing, but lower price does not establish equivalence in formulation, testing, or FDA review.
• Regulation: Branded drugs go through full FDA approval. Compounded medications are regulated under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
• Customization: Compounded medications can be prepared in specific dosages or formulations that may not be commercially available.

503A vs. 503B Pharmacies

Not all compounding pharmacies are the same. The distinction matters:

503A pharmacies compound medications based on individual patient prescriptions. They are regulated primarily by state boards of pharmacy.

503B outsourcing facilities operate under stricter FDA oversight. They can produce larger batches without individual prescriptions, must follow Current Good Manufacturing Practices (cGMP), and are subject to FDA inspections.

At Varus, we work with licensed pharmacies where appropriate. Availability, evidence strength, and regulatory status vary by treatment, and some compounds are discussed on a waitlist basis rather than actively offered.

Questions to Ask About Compounded Medications

Before starting any compounded medication, consider asking:

1. Is the pharmacy a 503A or 503B facility?
2. Are certificates of analysis available for each batch?
3. What quality controls are in place during manufacturing?
4. What is the source of the active pharmaceutical ingredient?
5. How should the medication be stored, and what is the expiration date?

The Bottom Line

Compounded medications are a legitimate and regulated part of the pharmaceutical landscape, but they are not FDA-approved and should not be assumed to be interchangeable with branded drugs. The key is working with reputable pharmacies and providers who are transparent about sourcing, quality, evidence, and limitations.